Zhu Xue, Wang Ke, Zhang Kai, Pan Yi, Zhou Fanfan, Zhu Ling
Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Jiangsu Province, China.
Department of Internal Medicine, JiangYuan Hospital Affiliated to Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Jiangsu Province, China.
Anticancer Agents Med Chem. 2018;18(6):875-881. doi: 10.2174/1871520618666180108095148.
Retinoblastoma is the most common intraocular malignant tumor in childhood. Although external beam radiation and enucleation are effective to control retinoblastoma, eye salvage and vision preservation are still significant challenges. Polyphyllin I (PPI), a natural compound extracted from Paris polyphylla rhizomes, has a wide range of activities against many types of cancers. However, the potential effect of this herbal compound on retinoblastoma has not yet been investigated.
In the present study, we evaluated the cytotoxic effect of PPI on human retinoblastoma Y-79 cells as well as its underlying molecular mechanism. Our results indicated that PPI treatment significantly inhibited cell proliferation, arrested the cell cycle at G2/M phase and induced cell apoptosis of Y79 cells through the mitochondrial- dependent intrinsic pathway. Moreover, p53 is involved in PPI-induced cytotoxicity in human retinoblastoma Y-79 cells. Exposure to 10 μM PPI for 48 h dramatically induced the expression levels of p53, phosphorylated- p53 and acetylated-p53. Furthermore, blockade of p53 expression effectively attenuated PPI-induced cell cycle arrest and cell apoptosis in Y-79 cells.
These results demonstrated that PPI exhibits anti-proliferation effect on human retinoblastoma Y-79 cells through modulating p53 expression, stabilization and activation. This information shed light on the potential application of PPI in retinoblastoma therapy.
视网膜母细胞瘤是儿童期最常见的眼内恶性肿瘤。尽管外照射放疗和眼球摘除术对控制视网膜母细胞瘤有效,但挽救眼球和保留视力仍是重大挑战。重楼皂苷I(PPI)是从七叶一枝花根茎中提取的一种天然化合物,对多种癌症具有广泛的抗癌活性。然而,这种草药化合物对视网膜母细胞瘤的潜在作用尚未得到研究。
在本研究中,我们评估了PPI对人视网膜母细胞瘤Y-79细胞的细胞毒性作用及其潜在的分子机制。我们的结果表明,PPI处理显著抑制细胞增殖,使细胞周期停滞在G2/M期,并通过线粒体依赖性内在途径诱导Y79细胞凋亡。此外,p53参与了PPI诱导的人视网膜母细胞瘤Y-79细胞的细胞毒性作用。暴露于10μM PPI 48小时显著诱导p53、磷酸化-p53和乙酰化-p53的表达水平。此外,阻断p53表达可有效减弱PPI诱导的Y-79细胞的细胞周期停滞和细胞凋亡。
这些结果表明,PPI通过调节p53表达、稳定和激活,对人视网膜母细胞瘤Y-79细胞具有抗增殖作用。这些信息为PPI在视网膜母细胞瘤治疗中的潜在应用提供了线索。